Jesper Eriksson 9/23/26 Jesper Eriksson 9/23/26 Virenc drug candidate shows strong antiviral effect against SARS-CoV-2 Read More Jesper Eriksson 9/17/26 Jesper Eriksson 9/17/26 Virenc receives innovation funding from Region Örebro County Read More Jesper Eriksson 9/14/26 Jesper Eriksson 9/14/26 Daniel Aili joins the Board of Virenc Read More Jesper Eriksson 4/8/26 Jesper Eriksson 4/8/26 Virenc wins Innovator of the Year 2026 Read More Jesper Eriksson 2/11/26 Jesper Eriksson 2/11/26 Virenc nominated for Innovator of the Year 2026 Read More Jesper Eriksson 1/28/26 Jesper Eriksson 1/28/26 Antiviral effects in a unique airway model – important collaboration with a renowned virologist Read More Jesper Eriksson 8/28/25 Jesper Eriksson 8/28/25 IRP certification prepares Virenc to engage with investors: “Extremely valuable” Read More Jesper Eriksson 8/20/25 Jesper Eriksson 8/20/25 Life science innovators from Örebro University met investors: “Valuable feedback” Read More Jesper Eriksson 11/4/24 Jesper Eriksson 11/4/24 Researchers’ discovery has the potential to slow the next pandemic Read More
Jesper Eriksson 9/23/26 Jesper Eriksson 9/23/26 Virenc drug candidate shows strong antiviral effect against SARS-CoV-2 Read More
Jesper Eriksson 9/17/26 Jesper Eriksson 9/17/26 Virenc receives innovation funding from Region Örebro County Read More
Jesper Eriksson 2/11/26 Jesper Eriksson 2/11/26 Virenc nominated for Innovator of the Year 2026 Read More
Jesper Eriksson 1/28/26 Jesper Eriksson 1/28/26 Antiviral effects in a unique airway model – important collaboration with a renowned virologist Read More
Jesper Eriksson 8/28/25 Jesper Eriksson 8/28/25 IRP certification prepares Virenc to engage with investors: “Extremely valuable” Read More
Jesper Eriksson 8/20/25 Jesper Eriksson 8/20/25 Life science innovators from Örebro University met investors: “Valuable feedback” Read More
Jesper Eriksson 11/4/24 Jesper Eriksson 11/4/24 Researchers’ discovery has the potential to slow the next pandemic Read More
